Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 198(1): 75-88, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36562909
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article